OTCMKTS:KWBT Kiwa Bio-Tech Products Group (KWBT) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free KWBT Stock Alerts $0.0002 0.00 (0.00%) (As of 09/25/2023) Add Compare Share Share Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.0001▼$0.0010Volume2,600 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Kiwa Bio-Tech Products Group alerts: Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About Kiwa Bio-Tech Products Group Stock (OTCMKTS:KWBT)Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.Read More KWBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KWBT Stock News HeadlinesMarch 18, 2024 | markets.businessinsider.comDupharma Biotech forms R&D partnerships for new therapiesFebruary 15, 2024 | realmoney.thestreet.comOne Small Biotech and Cannabis Are on My Mind as Market Laggards Fight BackApril 28, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. January 22, 2024 | bizjournals.comCanada's largest biotech acquires Gaithersburg firmJanuary 9, 2024 | investing.comChenguang Biotech Group (300138)January 5, 2024 | finanznachrichten.deShelly Group: Shelly Set to Launch Next Generation Products at CES 2024January 5, 2024 | msn.comUS biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on ChinaJuly 1, 2023 | techrepublic.comTop ProductsApril 28, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. June 28, 2023 | techrepublic.comSupport for these Microsoft enterprise products ends in 2023June 13, 2023 | wsj.comShenzhen Agricultural Products Group Co. Ltd. AMay 15, 2023 | investing.comFinancial Products Group Co Ltd (7148)March 10, 2023 | reuters.comCash is king in biotech M&A, but will clinical data be a saving grace?October 3, 2022 | finance.yahoo.comNew Partners to Restructure KIWAOctober 3, 2022 | finance.yahoo.comNew Partners to Restructure KIWASeptember 24, 2022 | marketwatch.comPHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and DevelopmentSeptember 17, 2022 | benzinga.comBioChain is officially a 10X Visium Certified Service Provider for spatial multiomics products and servicesSeptember 13, 2022 | benzinga.comKessler Topaz Meltzer & Check, LLP: Announces Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc.September 13, 2022 | washingtonpost.comBusiness Highlights: Twitter whistleblower, biotech pushSeptember 8, 2022 | benzinga.comThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of NIO, LTCH and ABTAugust 17, 2022 | benzinga.comKasada Named One of Australia's Best Workplaces by Great Place to Work®August 17, 2022 | msn.comNeedham Maintains Buy Rating for I-MAB: Here's What You Need To KnowAugust 15, 2022 | benzinga.comMitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Survival with RADICAVA® (edaravone)August 15, 2022 | yahoo.comBlack Bird Biotech Management Affirms Long-Term Commitment, Exchanges One-Third, over 120 Million, of Outstanding Common Shares for Preferred SharesAugust 5, 2022 | benzinga.comKibo Releases Subscriptions Management To Help Retailers Boost Revenue and Customer LoyaltyAugust 5, 2022 | benzinga.comTebra Named on Top 100 Healthcare Technology Companies of 2022August 1, 2022 | benzinga.comBioIVT Announces Promotion of Dr. Richard Haigh to CEOSee More Headlines Receive KWBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kiwa Bio-Tech Products Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/20/2018Today4/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBasic Materials Industry Agricultural chemicals Sub-IndustryN/A Current SymbolOTCMKTS:KWBT CUSIPN/A CIK1159275 Webwww.kiwabiotech.com Phone(909) 456-8828Fax626-626-7665Employees16Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta1.97 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Ziqi WangChief Exec. OfficerMr. Chaozhao ZhaoExec. Pres & GM of Mining Bus. DepartmentMr. Sen YangChief Financial OfficerMr. Boyu LiuChief Operating OfficerMr. Dadong LiExec. VPMr. Mingzheng BaoCAO & CPOProf. Qi Wang (Age 57)Director More ExecutivesKey CompetitorsChina Agri-BusinessOTCMKTS:CHBUAben MineralsOTCMKTS:ABNAFAbraSilver ResourceOTC:ABBRFAcadian TimberOTCMKTS:ACAZFAccsys TechnologiesOTCMKTS:ACSYFView All Competitors KWBT Stock Analysis - Frequently Asked Questions How have KWBT shares performed in 2024? Kiwa Bio-Tech Products Group's stock was trading at $0.0002 at the beginning of 2024. Since then, KWBT stock has increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here. How were Kiwa Bio-Tech Products Group's earnings last quarter? Kiwa Bio-Tech Products Group Co. (OTCMKTS:KWBT) announced its quarterly earnings results on Tuesday, November, 20th. The company reported $0.04 EPS for the quarter. The firm had revenue of $7.73 million for the quarter. What other stocks do shareholders of Kiwa Bio-Tech Products Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Kiwa Bio-Tech Products Group investors own include Co-Diagnostics (CODX), BioRestorative Therapies (BRTX), FuelCell Energy (FCEL), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Aurora Cannabis (ACB) and Ascent Solar Technologies (ASTI). How do I buy shares of Kiwa Bio-Tech Products Group? Shares of KWBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:KWBT) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiwa Bio-Tech Products Group Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
